CoronaVac COVID-19 Vaccine-Induced Anaphylaxis: Clinical Characteristics and Revaccination Outcomes

Autor: Laisuan W, Wongsa C, Chiewchalermsri C, Thongngarm T, Rerkpattanapipat T, Iamrahong P, Ruangwattanachok C, Nanthapisal S, Sompornrattanaphan M

Publikováno v: Journal of Asthma and Allergy, Vol Volume 14, Pp 1209-1215 (2021)

Wannada Laisuan,1 Chamard Wongsa,2 Chirawat Chiewchalermsri,3 Torpong Thongngarm,2 Ticha Rerkpattanapipat,1 Pansa Iamrahong,4 Chulapha Ruangwattanachok,4 Sira Nanthapisal,5 Mongkhon Sompornrattanaphan2 1Division of Allergy, Immunology and Rheumatolog

Externí odkaz: https://doaj.org/article/090efbc9c32f4473b722421e469144b0

Promoting patient-centred care in the management of allergic rhinitis in Asia-Pacific countries.

Autor: Chantaphakul H; Division of Allergy and Clinical Immunology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Wang Y; Department of Otolaryngology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Hang TTT; ORL Department, Tam Anh General Hospital, Ho Chi Minh City, Viet Nam., Kadir KA; Hospital Pakar An Nur, Bandar Baru Bangi, Malaysia., Lam HT; Unit of Allergy and Clinical Immunology, University Medical Center, Ho Chi Minh City, Viet Nam., Navarro-Locsin CG; Philippine Children's Medical Center, Philippines, and St. Luke's Medical Center, Quezon City, Philippines., Nanthapisal S; Division of Allergy, Immunology, and Rheumatology, Thammasat University, Pathumthani, Thailand., Poblete D; AMSI Doctors Medical Center, Calamba, Philippines., Tantilipikorn P; Center of Research Excellence in Allergy & Immunology, Faculty of Medicine, Siriraj Hospital, Thailand., Tong WH; Sunway Medical Centre, Kuala Lumpur, Malaysia., Nagrale D; Menarini Asia-Pacific Pte Ltd, Singapore., Lucas M; Department of Immunology, QE Medical Centre, Sir Charles Gairdner Hospital, Perth Children's Hospital, University of Western Australia, Perth, Australia.; Medical School, University of Western Australia, Perth, Australia.

Publikováno v: The World Allergy Organization journal [World Allergy Organ J] 2024 Aug 22; Vol. 17 (9), pp. 100952. Date of Electronic Publication: 2024 Aug 22 (Print Publication: 2024).

Inhibitory effect of Zingiber cassumunar Roxb. (Phlai) on nasal cytokine productions and eosinophilic recruitment in patients with allergic rhinitis.

Autor: Achararit N; Center of Excellence for Allergy, Asthma and Pulmonary Disease, Thammasat University Hospital, Pathumthani, Thailand.; Department of Pediatrics, Faculty of Medicine, Thammasat University, Pathumthani, Thailand., Tharabenjasin P; Chulabhorn International College of Medicine, Thammasat University, Pathumthani, Thailand., Kulalert P; Center of Excellence for Allergy, Asthma and Pulmonary Disease, Thammasat University Hospital, Pathumthani, Thailand.; Department of Pediatrics, Faculty of Medicine, Thammasat University, Pathumthani, Thailand., Sritipsukho P; Center of Excellence for Allergy, Asthma and Pulmonary Disease, Thammasat University Hospital, Pathumthani, Thailand.; Department of Pediatrics, Faculty of Medicine, Thammasat University, Pathumthani, Thailand., Nanthapisal S; Center of Excellence for Allergy, Asthma and Pulmonary Disease, Thammasat University Hospital, Pathumthani, Thailand.; Department of Pediatrics, Faculty of Medicine, Thammasat University, Pathumthani, Thailand., Pabalan N; Chulabhorn International College of Medicine, Thammasat University, Pathumthani, Thailand., Krishnamra N; Center of Excellence for Allergy, Asthma and Pulmonary Disease, Thammasat University Hospital, Pathumthani, ThailandCenter of Calcium and Bone Research (COCAB), Faculty of Science, Mahidol University, Bangkok, Thailand.; Department of Physiology, Faculty of Science, Mahidol University, Bangkok, Thailand., Suntornsaratoon P; Center of Excellence for Allergy, Asthma and Pulmonary Disease, Thammasat University Hospital, Pathumthani, ThailandCenter of Calcium and Bone Research (COCAB), Faculty of Science, Mahidol University, Bangkok, Thailand.; Department of Physiology, Faculty of Science, Mahidol University, Bangkok, Thailand., Poachanukoon O; Center of Excellence for Allergy, Asthma and Pulmonary Disease, Thammasat University Hospital, Pathumthani, Thailand.; Department of Pediatrics, Faculty of Medicine, Thammasat University, Pathumthani, Thailand.; Thammasat Universiy Research Unit in Allergy and Respiratory Medicine, Faculty of Medicine, Thammasat University, Pathumthani, Thailand.

Publikováno v: Asian Pacific journal of allergy and immunology [Asian Pac J Allergy Immunol] 2024 Mar; Vol. 42 (1), pp. 14-23.

Immunogenicity and reactogenicity of fractional, heterologous primary COVID-19 vaccination schedules with BNT162b2 boosters in 5-11-year-old Thai children: A multicenter, prospective, double-blind, randomized control trial.

Autor: Wittawatmongkol O; Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand., Bunjoungmanee P; Department of Pediatrics, Faculty of Medicine, Thammasat University, Pathum Thani 12120, Thailand; Clinical Research Center, Faculty of Medicine, Thammasat University, Pathum Thani 12120, Thailand., Kosalaraksa P; Department of Pediatrics, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand., Laoprasopwattana K; Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand., Boonsathorn S; Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand., Chantasrisawad N; Center of Excellence for Pediatric Infectious Diseases and Vaccines, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand., Sudjaritruk T; Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand., Niyomnaitham S; Department of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand; Siriraj Institute of Clinical Research (SICRES), Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand., Senawong S; Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand., Srisutthisamphan K; Virology and Cell Technology Research Team, National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA), Pathum Thani 12120, Thailand., Quan Toh Z; Department of Pediatrics, The University of Melbourne, Parkville, Victoria 3010, Australia; Infection and Immunity, Murdoch Children's Research Institute, Parkville, Victoria 3052, Australia., Rungmaitree S; Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand., Nanthapisal S; Department of Pediatrics, Faculty of Medicine, Thammasat University, Pathum Thani 12120, Thailand; Clinical Research Center, Faculty of Medicine, Thammasat University, Pathum Thani 12120, Thailand; Research Unit in Infectious and Immunology, Faculty of Medicine, Thammasat University, Pathum Thani 12120, Thailand., Phanthanawiboon S; Department of Microbiology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand., Khantee P; Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand., Techasaensiri C; Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand., Hirankarn N; Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand., Pangprasertkul S; Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand., Chokephaibulkit K; Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand; Siriraj Institute of Clinical Research (SICRES), Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand. Electronic address: kulkanya.cho@mahidol.ac.th.

Publikováno v: Vaccine [Vaccine] 2023 Sep 15; Vol. 41 (40), pp. 5834-5840. Date of Electronic Publication: 2023 Aug 14.

Single Ad26.COV2.S booster dose following two doses of BBIBP-CorV vaccine against SARS-CoV-2 infection in adults: Day 28 results of a phase 1/2 open-label trial.

Autor: Muangnoicharoen S; Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, 420/6 Ratchawithi Road, Ratchathewi, Bangkok 10400, Thailand., Wiangcharoen R; Phaholpolpayuhasena Hospital, 572 Saeng Chuto Road Muang, Kanchanaburi 71000, Thailand., Nanthapisal S; Faculty of Medicine, Thammasat University (Rangsit Campus), Pathum Thani, Thailand., Kamolratakul S; Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, 420/6 Ratchawithi Road, Ratchathewi, Bangkok 10400, Thailand., Lawpoolsri S; Center of Excellence for Biomedical and Public Health Informatics (BIOPHICS), Bangkok, Thailand; Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand., Jongkaewwattana A; National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA), Pathum Thani, Thailand., Thitithanyanont A; Faculty of Science, Mahidol University, Bangkok, Thailand., Luvira V; Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, 420/6 Ratchawithi Road, Ratchathewi, Bangkok 10400, Thailand., Chinwangso P; Center of Excellence for Biomedical and Public Health Informatics (BIOPHICS), Bangkok, Thailand., Thanthamnu N; Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, 420/6 Ratchawithi Road, Ratchathewi, Bangkok 10400, Thailand., Chantratita N; Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand., Lim JK; International Vaccine Institute, Seoul, Republic of Korea., Anh Wartel T; International Vaccine Institute, Seoul, Republic of Korea., Excler JL; International Vaccine Institute, Seoul, Republic of Korea., Ryser MF; Janssen Global Medical Affairs, Beerse, Belgium., Leong C; Janssen Asia Pacific Medical Affairs Operations, Sydney, Australia., Mak TK; Centre of Regulatory Excellence, Duke-NUS Medical School, Singapore; Vaccine and Infectious Disease Organization, University of Saskatchewan, Canada., Pitisuttithum P; Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, 420/6 Ratchawithi Road, Ratchathewi, Bangkok 10400, Thailand. Electronic address: punnee.pit@mahidol.ac.th.

Publikováno v: Vaccine [Vaccine] 2023 Jul 19; Vol. 41 (32), pp. 4648-4657. Date of Electronic Publication: 2023 Jun 15.